Earliest phases of chondrogenesis are dependent upon angiogenesis during ectopic bone formation in mice

Bone

Volumn 101, Issue , 2017, Pages 49-61

  Bragdon, Beth ^a   Lam, Stephanie ^a   Aly, Sherif ^a   Femia, Alexandra ^a   Clark, Abigail ^a   Hussein, Amira ^a   Morgan, Elise F ^b   Gerstenfeld, Louis C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

Author keywords

Angiogenesis; Cartilage biology; Chondrocytes; Developmental modeling; Endochondral ossification

Indexed keywords

BLOCKING ANTIBODY; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; CYCLOHEXANE DERIVATIVE; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL; RIBOSOME RNA; SESQUITERPENE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE MATRIX; BONE MINERALIZATION; BONE RADIOGRAPHY; CELL DIFFERENTIATION; CELLS BY BODY ANATOMY; CHONDROGENESIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FRACTURE HEALING; INFLAMMATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; VASCULAR ENDOTHELIAL CELL; ANIMAL; BONE DEVELOPMENT; CARTILAGE; CHONDROCYTE; CYTOLOGY; DRUG EFFECTS; HUMAN; IMMUNOHISTOCHEMISTRY; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BONE DEVELOPMENT; CARTILAGE; CHONDROCYTES; CHONDROGENESIS; CYCLOHEXANES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL; SESQUITERPENES;

EID: 85018550505     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2017.04.002     Document Type: Article

References (51)

1. [1] Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A., de Crombrugghe, B., The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 16, 2002, 2813-28.
2. [2] Akiyama, H., Lefebvre, V., Unraveling the transcriptional regulatory machinery in chondrogenesis. J. Bone Miner. Metab. 29 (2011), 390–395.
3. [3] Kondo, M., Yamaoka, K., Sonomoto, K., Fukuyo, S., Oshita, K., Okada, Y., Saito, K., Tanaka, Y., OP0307 inhibitory effects of IL-17 on chondrogenic differentiation of human mesenchymal stem cells through the phosphorylation of Sox9. Ann. Rheum. Dis., 72, 2013, A158.
4. [4] Oberlender, S.A., Tuan, R.S., Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120 (1994), 177–187.
5. [5] Marcucio, R., Hu, D., Yang, F., Bahney, C., Miclau, T., Transdifferentiation of chondrocytes to osteoblasts during bone fracture healing. FASEB J., 30, 2016 (223.1, 223.1).
6. [6] Zhou, X., von der Mark, K., Henry, S., Norton, W., Adams, H., de Crombrugghe, B., Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet., 10, 2014, e1004820.
7. [7] Gerber, H., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., Ferrara, N., VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med., 5, 1999, 623-8.
8. [8] Zelzer, E., Olsen, B.R., Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr. Top. Dev. Biol. 65 (2004), 169–187.
9. [9] Zelzer, E., McLean, W., Ng, Y.S., Fukai, N., Reginato, A.M., Lovejoy, S., D'Amore, P.A., Olsen, B.R., Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129 (2002), 1893–1904.
10. [10] Ai-Aql, Z.S., Alagl, A.S., Graves, D.T., Gerstenfeld, L.C., Einhorn, T.A., Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J. Dent. Res. 87 (2008), 107–118.
11. [11] Garcia, P., Pieruschka, A., Klein, M., Tami, A., Histing, T., Holstein, J.H., Scheuer, C., Pohlemann, T., Menger, M.D., Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins. J. Bone Joint Surg. Am. 94 (2012), 49–58.
12. [12] Altman, R.D., Latta, L., Keer, R., Renfree, K., Hornicek, F., Banovac, K., Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J. Orthop. Trauma 9 (1995), 392–400.
13. [13] Tomlinson, R.E., McKenzie, J.A., Schmieder, A.H., Wohl, G.R., Lanza, G.M., Silva, M.J., Angiogenesis is required for stress fracture healing in rats. Bone, 52, 2013, 212-9.
14. [14] Fang, T.D., Salim, A., Xia, W., Nacamuli, R.P., Guccione, S., Song, H.M., Carano, R.A., Filvaroff, E.H., Bednarski, M.D., Giaccia, A.J., Longaker, M.T., Angiogenesis is required for successful bone induction during distraction osteogenesis. J. Bone Miner. Res. 20 (2005), 1114–1124.
15. [15] Hausman, M., Schaffler, M., Majeska, R., Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone, 29, 2001, 560-4.
16. [16] Wang, J., Lou, P., Henkin, J., Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. J. Cell. Biochem. 77 (2000), 465–473.
17. [17] Kusaka, M., Sudo, K., Matsutani, E., Kozai, Y., Marui, S., Fujita, T., Ingber, D., Folkman, J., Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer 69 (1994), 212–216.
18. [18] Mori, S., Yoshikawa, H., Hashimoto, J., Ueda, T., Funai, H., Kato, M., Takaoka, K., Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone 22 (1998), 99–105.
19. [19] Witte, L., Hicklin, D.J., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P., Böhlen, P., Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev. 17 (1998), 155–161.
20. [20] Jacobsen, K.A., Al-Aql, Z.S., Wan, C., Fitch, J.L., Stapleton, S.N., Mason, Z.D., Cole, R.M., Gilbert, S.R., Clemens, T.L., Morgan, E.F., Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J. Bone Miner. Res. 23 (2008), 596–609.
21. [21] Mombaerts, P., Iacomini, J., Johnson, R.S., Herrup, K., Tonegawa, S., Papaioannou, V.E., RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68 (1992), 869–877.
22. [22] Roche, B., David, V., Vanden-Bossche, A., Peyrin, F., Malaval, L., Vico, L., Lafage-Proust, M., Structure and quantification of microvascularisation within mouse long bones: what and how should we measure?. Bone, 50, 2012, 390-9.
23. [23] Matsubara, H., Hogan, D.E., Morgan, E.F., Mortlock, D.P., Einhorn, T.A., Gerstenfeld, L.C., Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone 51 (2012), 168–180.
24. [24] Morgan, E.F., Hussein, A.I., Al-Awadhi, B.A., Hogan, D.E., Matsubara, H., Al-Alq, Z., Fitch, J., Andre, B., Hosur, K., Gerstenfeld, L.C., Vascular development during distraction osteogenesis proceeds by sequential intramuscular arteriogenesis followed by intraosteal angiogenesis. Bone 51 (2012), 535–545.
25. [25] Sin, N., Meng, L., Wang, M.Q., Wen, J.J., Bornmann, W.G., Crews, C.M., The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 6099–6103.
26. [26] Shu, B., Zhang, M., Xie, R., Wang, M., Jin, H., Hou, W., Tang, D., Harris, S.E., Mishina, Y., O'Keefe, R.J., Hilton, M.J., Wang, Y., Chen, D., BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J. Cell Sci., 124, 2011, 3428-40.
27. [27] Kronenberg, H.M., Developmental regulation of the growth plate. Nature 423 (2003), 332–336.
28. [28] Lanske, B., Karaplis, A.C., Lee, K., Luz, A., PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science, 273, 1996, 663.
29. [29] Schwaerzer, G.K., Hiepen, C., Schrewe, H., Nickel, J., Ploeger, F., Sebald, W., Mueller, T., Knaus, P., New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance. J. Bone Miner. Res. 27 (2012), 429–442.
30. [30] Yang, Y., Topol, L., Lee, H., Wu, J., Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130 (2003), 1003–1015.
31. [31] Bandyopadhyay, A., Tsuji, K., Cox, K., Harfe, B.D., Rosen, V., Tabin, C.J., Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet., 2, 2006, e216.
32. [32] Engsig, M.T., Chen, Q.J., Vu, T.H., Pedersen, A.C., Therkidsen, B., Lund, L.R., Henriksen, K., Lenhard, T., Foged, N.T., Werb, Z., Delaisse, J.M., Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151 (2000), 879–889.
33. [33] Ortega, N., Behonick, D.J., Werb, Z., Matrix remodeling during endochondral ossification. Trends Cell Biol. 14 (2004), 86–93.
34. [34] Bragdon, B., Lybrand, K., Gerstenfeld, L., Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reaming. Curr. Protoc. Mouse Biol., 2015, 21–34.
35. [35] Street, J., Bao, M., de Guzman, L., Bunting, S., Peale, F.V. Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., Filvaroff, E.H., Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. U. S. A., 99, 2002, 9656-61.
36. [36] Dilling, C.F., Wada, A.M., Lazard, Z.W., Salisbury, E.A., Gannon, F.H., Vadakkan, T.J., Gao, L., Hirschi, K., Dickinson, M.E., Davis, A.R., Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification. J. Bone Miner. Res. 25 (2010), 1147–1156.
37. [37] Eshkar-Oren, I., Viukov, S.V., Salameh, S., Krief, S., Oh, C.D., Akiyama, H., Gerber, H.P., Ferrara, N., Zelzer, E., The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of vegf. Development, 136, 2009, 1263-72.
38. [38] Yin, M., Pacifici, M., Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb. Dev. Dyn. 222 (2001), 522–533.
39. [39] Yoon, B.S., Ovchinnikov, D.A., Yoshii, I., Mishina, Y., Behringer, R.R., Lyons, K.M., Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A., 102, 2005, 5062-7.
40. [40] Storm, E.E., Kingsley, D.M., GDF5 coordinates bone and joint formation during digit development. Dev. Biol. 209 (1999), 11–27.
41. [41] Retting, K.N., Song, B., Yoon, B.S., Lyons, K.M., BMP canonical smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136 (2009), 1093–1104.
42. [42] Zhang, Y., Yeh, J.R., Mara, A., Ju, R., Hines, J.F., Cirone, P., Griesbach, H.L., Schneider, I., Slusarski, D.C., Holley, S.A., A chemical and genetic approach to the mode of action of fumagillin. Chem. Biol., 13, 2006, 1001-9.
43. [43] Cirone, P., Lin, S., Griesbach, H.L., Zhang, Y., Slusarski, D.C., Crews, C.M., A role for planar cell polarity signaling in angiogenesis. Angiogenesis 11 (2008), 347–360.
44. [44] Markovič, R., Peltan, J., Gosak, M., Horvat, D., Žalik, B., Seguy, B., Chauvel, R., Malandain, G., Couffinhal, T., Duplàa, C., Planar cell polarity genes frizzled4 and frizzled6 exert patterning influence on arterial vessel morphogenesis. PLoS One, 12, 2017, e0171033.
45. [45] Descamps, B., Sewduth, R., Ferreira Tojais, N., Jaspard, B., Reynaud, A., Sohet, F., Lacolley, P., Allieres, C., Lamaziere, J.M., Moreau, C., Dufourcq, P., Couffinhal, T., Duplaa, C., Frizzled 4 regulates arterial network organization through noncanonical wnt/planar cell polarity signaling. Circ. Res. 110 (2012), 47–58.
46. [46] Bradley, E.W., Drissi, M.H., Wnt5b regulates mesenchymal cell aggregation and chondrocyte differentiation through the planar cell polarity pathway. J. Cell. Physiol. 226 (2011), 1683–1693.
47. [47] Sundberg, T.B., Darricarrere, N., Cirone, P., Li, X., McDonald, L., Mei, X., Westlake, C.J., Slusarski, D.C., Beynon, R.J., Crews, C.M., Disruption of wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37. Chem. Biol. 18 (2011), 1300–1311.
48. [48] Carlevaro, M.F., Cermelli, S., Cancedda, R., Descalzi Cancedda, F., Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113:Pt 1 (2000), 59–69.
49. [49] Bluteau, G., Julien, M., Magne, D., Mallein-Gerin, F., Weiss, P., Daculsi, G., Guicheux, J., VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 40 (2007), 568–576.
50. [50] Ohba, S., Hedgehog signaling in endochondral ossification. J. Dev. Biol., 4, 2016, 20.
51. [51] Sandell, L.J., Adler, P., Developmental patterns of cartilage. Front. Biosci., 4, 1999 (D731-42).